| Literature DB >> 30390671 |
Tracy Schmidt1,2, Marleen M Kock3,4, Marthie M Ehlers3,4.
Abstract
BACKGROUND: Coagulase-negative staphylococci (CoNS) are among the leading bacterial causes of bovine mastitis in many dairy-producing countries. Among the challenges associated with the specific diagnosis of CoNS infections is the biochemical heterogeneity of the species in the genus and the unavailability of accurate, cost-effective and up-to-date diagnostic tests. A previous study investigating the diversity of CoNS associated with cases of bovine mastitis in South Africa, resulted in six CoNS isolates which could not be identified despite the use of a combination of different molecular assays. The identification and characterisation of the isolates was pursued further in this study.Entities:
Keywords: Biolog; Bovine mastitis; CoNS; MALDI-TOF MS; Staphylococcus devriesei
Mesh:
Year: 2018 PMID: 30390671 PMCID: PMC6215665 DOI: 10.1186/s12917-018-1655-1
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Preliminary characterization results for the coagulase-negative Staphylococcus isolates recovered from bovine intramammary infections
| Isolate reference (farm of origin) | Phenotyping assays | Multiplex PCR 1 | Species-level identification of CoNS isolates | Antimicrobial susceptibility testing | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coagulase production | Pastorex StaphPlus test | 16S rRNA genus-specific target | Bovine M-PCRa | MALDI-TOF MS (score)b | Penicillin (10 IU) | Ampicillin (10 μg) | Amoxicillin/Clavulanate (20 μg / 10 μg) | Cefoxitin (30 μg) | Cephalothin (30 μg) | Tetracycline (30 μg) | Trimethoprim/Sulfamethoxazole (1.25 μg / 23.75 μg) | Moxifloxacin (30 μg) | Clindamycin (2 μg) | Erythromycin (15 μg) | Gentamicin (10 μg) | Streptomycin (10 μg) | |||||
| AN3 (commercial farm A) | (−) | (−) | (+) | (−) | (−) | (−) | (−) | No reliable identification | c | R | R | S | S | S | S | S | S | S | S | S | S |
| AN19 (commercial farm A) | (−) | (−) | (+) | (−) | (−) | (−) | (−) | No reliable identification | c | S | S | S | S | S | S | S | S | S | S | S | S |
| AN22 (commercial farm A) | (−) | (−) | (+) | (−) | (−) | (−) | (−) | No reliable identification | c | S | S | S | S | S | S | S | S | S | S | S | S |
| AN25 (commercial farm A) | (−) | (−) | (+) | (−) | (−) | (−) | (−) | No reliable identification | c | R | R | S | S | S | S | S | S | S | S | S | S |
| BN7 (commercial farm B) | (−) | (−) | (+) | (−) | (−) | (−) | (−) | c | R | R | S | S | S | S | S | S | S | S | S | S | |
| FN2 (commercial farm F) | (−) | (−) | (+) | (−) | (−) | (−) | (−) | No reliable identification | d | S | S | S | S | S | S | S | S | S | S | S | S |
aThe bovine M-PCR assay comprised of primers specific for: S. chromogenes, S. epidermidis, S. haemolyticus, S. simulans, S. warneri and S. xylosus
bMALDI-TOF MS interpretation: 2.00 to 2.299 = secure genus identification, probably species identification; 1.70 to 1.99 = probable genus identification; < 1.7 = not a reliable identification
cAmplicon sequence showed 99–100% similarity with data in GenBank (EU571021)
dAmplicon showed 97% similarity to S. haemolyticus; (+) = positive; (−) = negative; S = sensitive; R = resistant
Metabolic fingerprints for six Staphylococcus devriesei isolates obtained using the Biolog GENIII Microplate™ identification system
| Assay | AN3 | AN19 | AN22 | AN25 | BN7 | FN2 | |
|---|---|---|---|---|---|---|---|
| Carbon sources | Dextrin | + | + | + | + | + | + |
| D-Maltose | + | + | + | + | + | + | |
| D-Trehalose | + | + | + | + | + | + | |
| D-Cellobiose | b | b | b | b | b | b | |
| Gentiobiose | + | + | b | b | b | + | |
| Sucrose | + | + | + | + | + | + | |
| D-Turanose | + | + | + | + | + | + | |
| Stachyose | b | b | b | b | (−) | b | |
| D-Raffinose | (−) | (−) | b | b | (−) | b | |
| α-D-Lactose | b | + | + | + | + | + | |
| D-Melibiose | b | b | b | b | b | b | |
| ß-Methyl-D-Glucoside | + | b | (−) | (−) | b | + | |
| D-Salicin | b | (−) | (−) | (−) | (−) | (−) | |
| N-Acetyl-D-Glucosamine | + | b | b | + | + | + | |
| N-Acetyl-β-D-Mannosamine | + | b | b | + | b | + | |
| N-Acetyl-D-Galactosamine | (−) | (−) | (−) | (−) | (−) | (−) | |
| N-Acetyl-Neuraminic Acid | + | + | + | + | + | + | |
| α-D-Glucose | + | + | + | + | + | + | |
| D-Mannose | b | b | b | b | b | + | |
| D-Fructose | + | + | + | + | + | + | |
| D-Galactose | + | + | + | + | + | + | |
| 3-Methyl Glucose | b | b | b | b | b | b | |
| D-Fucose | b | b | b | b | b | b | |
| L-Fucose | b | b | b | b | b | b | |
| L-Rhamnose | b | b | b | b | b | b | |
| Inosine | b | + | + | + | + | + | |
| D-Sorbitol | b | b | b | b | b | b | |
| D-Mannitol | + | b | + | + | + | + | |
| D-Arabitol | + | + | b | b | + | + | |
| myo-Inositol | (−) | (−) | (−) | b | (−) | b | |
| Glycerol | + | + | + | + | + | + | |
| D-Glucose-6-PO4 | b | b | b | b | b | b | |
| D-Fructose-6-PO4 | b | b | b | b | b | b | |
| D-Aspartic acid | b | b | (−) | b | (−) | b | |
| D-Serine | (−) | (−) | (−) | (−) | (−) | b | |
| Gelatin | b | b | (−) | (−) | (−) | b | |
| Glycyl-L-Proline | (−) | + | b | (−) | b | b | |
| L-Alanine | + | + | + | + | + | + | |
| L-Arginine | + | + | (−) | (−) | (−) | + | |
| L-Aspartic Acid | b | b | (−) | b | (−) | + | |
| L-Glutamic Acid | + | + | b | b | + | + | |
| L-Histidine | (−) | (−) | (−) | (−) | (−) | (−) | |
| L-Pyroglutamic Acid | (−) | (−) | b | b | b | + | |
| L-Serine | + | + | (−) | + | + | + | |
| Pectin | + | + | + | + | + | + | |
| D-Galacturonic Acid | b | b | b | b | b | b | |
| L-Galactonic Acid Lactone | b | b | b | b | b | b | |
| D-Gluconic Acid | + | + | + | + | + | + | |
| D-Glucuronic Acid | b | b | b | b | b | b | |
| Glucuronamide | b | b | b | b | b | b | |
| Mucic Acid | (−) | (−) | (−) | b | b | b | |
| Quinic Acid | (−) | (−) | (−) | (−) | (−) | b | |
| D-Saccharic Acid | b | b | (−) | b | b | b | |
| (−) | (−) | (−) | (−) | (−) | (−) | ||
| Methyl Pyruvate | + | + | + | + | + | + | |
| D-Lactic Acid Methyl Ester | b | b | b | b | b | b | |
| L-Lactic Acid | + | + | + | + | + | + | |
| Citric Acid | + | + | + | + | + | + | |
| α-Keto-Glutaric Acid | (−) | (−) | b | b | b | b | |
| D-Malic Acid | (−) | (−) | (−) | (−) | (−) | (−) | |
| L-Malic Acid | b | b | + | + | + | + | |
| Bromo-Succinic Acid | (−) | (−) | b | (−) | (−) | b | |
| Tween 40 | b | + | b | b | b | + | |
| γ-Amino-Butyric Acid | (−) | (−) | (−) | (−) | (−) | (−) | |
| α-Hydroxy-Butyric Acid | b | + | + | b | + | + | |
| β-Hydroxy-D,L-Butyric Acid | (−) | (−) | (−) | (−) | (−) | (−) | |
| α-Keto-Butyric Acid | + | b | + | b | b | b | |
| Acetoacetic Acid | + | + | + | + | + | + | |
| Propionic Acid | + | b | b | + | b | + | |
| Acetic Acid | + | + | b | + | b | + | |
| Formic Acid | + | (−) | + | + | + | + | |
| Chemical sensitivity assays | pH 6 | + | + | + | + | + | + |
| pH 5 | b | b | (−) | (−) | (−) | b | |
| 1% NaCl | + | + | + | + | + | + | |
| 4% NaCl | + | + | + | + | + | + | |
| 8% NaCl | + | + | + | + | + | + | |
| 1% Sodium Lactate | + | + | + | + | + | + | |
| Fusidic acid | (−) | (−) | (−) | (−) | (−) | (−) | |
| D-Serine | + | + | + | b | + | + | |
| Troleandomycin | (−) | (−) | (−) | (−) | (−) | (−) | |
| Rifamycin SV | (−) | (−) | (−) | (−) | (−) | (−) | |
| Minocycline | (−) | (−) | (−) | (−) | (−) | (−) | |
| Lincomycin | (−) | (−) | (−) | (−) | (−) | (−) | |
| Guanidine HCl | (−) | (−) | (−) | (−) | (−) | (−) | |
| Niaproof 4 | (−) | (−) | (−) | (−) | (−) | (−) | |
| Vancomycin | (−) | (−) | (−) | (−) | (−) | (−) | |
| Tetrazolium Violet | (−) | (−) | (−) | (−) | (−) | (−) | |
| Tetrazolium Blue | (−) | (−) | (−) | (−) | (−) | (−) | |
| Nalidixic Acid | + | + | + | + | + | + | |
| Lithium Chloride | + | + | + | + | + | + | |
| Potassium Tellurite | + | + | + | + | + | + | |
| Aztreonam | + | + | + | + | + | + | |
| Sodium Butyrate | + | + | + | + | + | + | |
| Sodium Bromate | b | b | (−) | b | b | b | |
+ = Positive; (−) = Negative; b = Borderline
Fig. 1Minimal spanning tree generated by MALDI biotyper 3.0 software showing the six Staphylococcus devriesei isolates under investigation. The tree was created by the standard MALDI biotyper MSP creation method where distance values are relative and are always normalized to a maximum value of 1.00
Amplification of the 16S rRNA, dnaJ, hsp60 and rpoB genes of the coagulase-negative Staphylococcus isolates
| Gene target | Primer name | Oligonucleotide sequencea (5′ – 3′) | PCR amplification conditions | Size of amplicon (bp) | Reference |
|---|---|---|---|---|---|
| 16S rRNA | 16F27 | AGAGTTTGATCCTGGCTCAG | 95 °C for 5 min, 30 cycles of [95 °C for 30 s, 58 °C for 60 s, 72 °C for 90 s] and a final extension step at 72 °C for 10 min | 1500 | [ |
| SA-(F) | GCCAAAAGAGACTATTATGA | 94 °C for 3 min, 5 cycles of [94 °C for 30 s, 45 °C for 30 s, 72 °C for 60 s], 30 cycles of [94 °C for 30 s, 50 °C for 30 s, 72 °C for 60 s], 72 °C for 3 min | 920 | [ | |
| hsp60-F | CAIIIGCIGGIGAYGGIACIACIAC | 94 °C for 2 min, [94 °C for 60 s, TDb for 2 min, 72 °C for 5 min], 20 cycles of [94 °C for 60 s, 35 °C for 2 min, 72 °C for 5 min], 72 °C for 10 min | 600 | [ | |
| 1418f | CAATTCATGGACCAAGC | 94 °C for 5 min; 30 cycles of [94 °C for 45 s, 52 °C for 60 s, 72 °C for 90 s]; 72 °C for 10 min | 899 | [ |
aAll primers were synthesized by Inqaba Biotechnical Industries (South Africa)
bTD = Touchdown PCR from 45 °C to 35 °C with temperature decrease of 0.5 °C per cycle; I Inosine, K Keto (G or T), Y pyrimidine (C or T)